SCHEDULE 13G: Glazer Capital and Paul J. Glazer Disclose 6.71% Stake in Aimei Health Technology
Beneficial Ownership Report
Glazer Capital, LLC and Paul J. Glazer have reported a beneficial ownership of 6.71% in Aimei Health Technology Co Ltd, totaling 605,795 ordinary shares as of December 31, 2024.
Summary
- Glazer Capital, LLC and Paul J. Glazer (the "Reporting Persons") have filed a Schedule 13G with the SEC.
- The Reporting Persons collectively beneficially own 605,795 ordinary shares of Aimei Health Technology Co Ltd.
- This ownership represents 6.71% of the issuer's outstanding ordinary shares.
- The shares are held by certain funds and managed accounts for which Glazer Capital serves as investment manager.
- Glazer Capital, LLC and Paul J. Glazer possess shared voting power and shared dispositive power over all 605,795 shares.
- The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing disclosing a significant passive ownership stake. While neutral in its direct content, the disclosure of a substantial investment by a known investment firm can be perceived positively by the market as a vote of confidence.
Positives
- Glazer Capital, LLC and Paul J. Glazer have acquired a significant beneficial ownership stake of 6.71% in Aimei Health Technology Co Ltd, indicating a notable investment by a recognized firm.
Future Outlook
The document, a Schedule 13G, is a disclosure of passive beneficial ownership and does not contain any forward-looking statements or guidance regarding the issuer's future performance or strategic direction.
Industry Context
This Schedule 13G filing is a routine regulatory disclosure of a significant passive ownership stake and does not provide specific insights into broader industry trends or competitive dynamics within the health technology sector.
Stakeholder Impact
- Shareholders: Provides increased transparency regarding the ownership structure of Aimei Health Technology Co Ltd, specifically highlighting a new significant passive investor. This can potentially influence investor sentiment positively.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (end of reporting period for ownership calculation). |
| 02/14/2025 | Date of filing of the Schedule 13G statement. |
Keywords
Aimei Health Technology, Glazer Capital, Paul J. Glazer, Schedule 13G, beneficial ownership, ordinary shares, SEC filing, investment, stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.